부산대학교 도서관

Demajo, S.; Sánchez-Guixé, M.; Muiños, F.; Brando, F.; Ramis-Zaldívar, J.E.; Grau, M.; Rosa, P. Gomis; Pellegrini, S.; López-Elorduy, C.; Tort, O.; Gonzalez-Perez, A.; López-Bigas, N.

ESMO Open. 9

Albert Gris-Oliver; Yasir H. Ibrahim; Martín A. Rivas; Celina García-García; Mònica Sánchez-Guixé; Fiorella Ruiz-Pace; Cristina Viaplana; José M. Pérez-García; Antonio Llombart-Cussac; Judit Grueso; Mireia Parés; Marta Guzmán; Olga Rodríguez; Pilar Anton; Patricia Cozar; Maria Teresa Calvo; Alejandra Bruna; Joaquín Arribas; Carlos Caldas; Rodrigo Dienstmann; Paolo Nuciforo; Mafalda Oliveira; Javier Cortés; Violeta Serra

BRITISH JOURNAL OF CANCER
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

S. Demajo; O. Tort; M. Sánchez-Guixé; F. Muiños; P. Gomis Rosa; C. López-Elorduy; M. Guardiola Fernandez; F. Brando; M. Grau; J. Deu-Pons; A. Gonzalez-Perez; N. López-Bigas

Annals of Oncology. 35:S768

Martínez-Millán D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Brando F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; L Grau M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Sánchez-Guixé M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.; López-Elorduy C; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Reyes-Salazar I; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Deu-Pons J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.; López-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 08003, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010, Spain.; González-Pérez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, 28029, Spain.; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 08003, Spain.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9808944 Publication Model: Print Cited Medium: Internet ISSN: 1367-4811 (Electronic) Linking ISSN: 13674803 NLM ISO Abbreviation: Bioinformatics Subsets: MEDLINE

Palafox M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Monserrat L; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Bellet M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Villacampa G; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Oliveira M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Ibrahimi N; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; Kannan S; Bioinformatics Institute (ASTAR), Singapore, Singapore.; Mina L; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Herrera-Abreu MT; The Breast Cancer Now Research Centre, London, UK.; Òdena A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Capelán M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Azaro A; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Bruna A; Preclinical Modelling of Pediatric Cancer Evolution Group, The Institute of Cancer Research, London, UK.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Viaplana C; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Hernández J; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.; Su F; Novartis Pharmaceuticals, East Hanover, NJ, USA.; Lin K; Genentech, Inc., South San Francisco, California, USA.; Clarke RB; Breast Biology Group, Manchester Breast Centre, Manchester, UK.; Caldas C; Cancer Research UK, Cambridge, UK.; Arribas J; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Growth Factors Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; García-Sanz A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Turner NC; The Breast Cancer Now Research Centre, London, UK.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Oncology, IOB Institute of Oncology, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Verma CS; Bioinformatics Institute (ASTAR), Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Scaltriti M; Departments of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Inserm Unit U981, Villejuif, France.; Saura C; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Palafox M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Monserrat L; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Bellet M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Villacampa G; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Gonzalez-Perez A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Oliveira M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Ibrahimi N; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; Kannan S; Bioinformatics Institute (ASTAR), Singapore, Singapore.; Mina L; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Herrera-Abreu MT; The Breast Cancer Now Research Centre, London, UK.; Òdena A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Capelán M; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Azaro A; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Bruna A; Preclinical Modelling of Pediatric Cancer Evolution Group, The Institute of Cancer Research, London, UK.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Viaplana C; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Hernández J; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.; Su F; Novartis Pharmaceuticals, East Hanover, NJ, USA.; Lin K; Genentech, Inc., South San Francisco, California, USA.; Clarke RB; Breast Biology Group, Manchester Breast Centre, Manchester, UK.; Caldas C; Cancer Research UK, Cambridge, UK.; Arribas J; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Growth Factors Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.; Oncostat U1018, Inserm, University Paris-Saclay, Villejuif, France.; García-Sanz A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Turner NC; The Breast Cancer Now Research Centre, London, UK.; Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Department of Oncology, IOB Institute of Oncology, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Verma CS; Bioinformatics Institute (ASTAR), Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Scaltriti M; Departments of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Inserm Unit U981, Villejuif, France.; Saura C; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Sánchez-Guixé M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Muiños F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Pinheiro-Santin M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; González-Huici V; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Rodriguez-Hernandez CJ; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Avgustinova A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Lavarino C; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Barcelona, Spain.; González-Pérez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.; Mora J; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Barcelona, Spain.; López-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

C. Hierro; M. Sánchez-Guixé; J. Jiménez; E. Garralda; C. Saura; P. Nuciforo; A. Vivancos; J. Tabernero; J. Rodon; V. Serra

Annals of Oncology. 31:S9-S10

Lawson M; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Cureton N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Ros S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Cheraghchi-Bashi A; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Urosevic J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; D'Arcy S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Delpuech O; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; DuPont M; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Fisher DI; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Gangl ET; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Lewis H; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Trueman D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Wali N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Williamson SC; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Moss J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Montaudon E; Institut Curie, Paris, France.; Derrien H; Institut Curie, Paris, France.; Marangoni E; Institut Curie, Paris, France.; Miragaia RJ; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Gagrica S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Morentin-Gutierrez P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Moss TA; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Maglennon G; Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Sutton D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Polanski R; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Rosen A; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.; Cairns J; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Zhang P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Critchlow SE; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Scott JS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Lindemann JPO; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Barry ST; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; Morrow CJ; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.; Carnevalli LS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Heimdal, Ketil; Sanchez-Guixé, Monica; Aukrust, Ingvild; Bollerslev, Jens; Bruland, Ove; Jablonski, Greg Eigner; Erichsen, Anne Kjersti; Gude, Einar; Koht, Jeanette A.; Erdal, Sigrid; Fiskerstrand, Torunn; Haukanes, Bjørn Ivar; Boman, Helge; Bjørkhaug, Lise; Tallaksen, Chantal M. E.; Knappskog, Per; Johansson, Stefan

Orphanet J Rare Dis
Orphanet Journal of Rare Diseases

C. Hierro; M. Sánchez-Guixé; F. Ruiz-Pace; J. Jimenez; L. Maynes; A. Azaro; J. Martin-Liberal; M. Ochoa de Olza; I. Braña; M. Vieito; A. Villanueva; H.G. Palmer; J. Arribas; P. Nuciforo; A. Vivancos; E. Garralda; R. Dienstmann; J. Tabernero; V. Serra; J. Rodon

Annals of Oncology. 28:v575

Gris-Oliver, Albert; Ibrahim, Yasir H.; Rivas, Martín A.; García-García, Celina; Sánchez-Guixé, Mònica; Ruiz-Pace, Fiorella; Viaplana, Cristina; Pérez-García, José M.; Llombart-Cussac, Antonio; Grueso, Judit; Parés, Mireia; Guzmán, Marta; Rodríguez, Olga; Anton, Pilar; Cozar, Patricia; Calvo, Maria Teresa; Bruna, Alejandra; Arribas, Joaquín; Caldas, Carlos; Dienstmann, Rodrigo; et al

British Journal of Cancer (BR J CANCER), Apr2021; 124(9): 1581-1591. (11p)

Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Hierro C; Medical Oncology Department, Vall d'Hebron University Hospital (VHUH), Barcelona, Spain.; Molecular Therapeutics Research Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Jiménez J; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Viaplana C; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Villacampa G; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Monelli E; ProCURE, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); Hospitalet de Llobregat, Barcelona, Spain.; Brasó-Maristany F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Ogbah Z; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Parés M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital (VHUH), Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Azaro A; Medical Oncology Department, Vall d'Hebron University Hospital (VHUH), Barcelona, Spain.; Molecular Therapeutics Research Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital (VHUH), Barcelona, Spain.; Molecular Therapeutics Research Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital (VHUH), Barcelona, Spain.; Molecular Therapeutics Research Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Casanovas O; ProCURE, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); Hospitalet de Llobregat, Barcelona, Spain.; Scaltriti M; Human Oncology and Pathogenesis Program and Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Prat A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Medical Oncology Department, Hospital Clínic de Barcelona, Barcelona, Spain.; Dienstmann R; Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Saura C; Medical Oncology Department, Vall d'Hebron University Hospital (VHUH), Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Graupera M; ProCURE, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red Cáncer (ciberonc), Barcelona, Spain.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Rodon J; Investigational Cancer Therapeutics Department and Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. vserra@vhio.net JRodon@mdanderson.org.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. vserra@vhio.net JRodon@mdanderson.org.; Centro de Investigación Biomédica en Red Cáncer (ciberonc), Barcelona, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Pakdaman Y; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Sanchez-Guixé M; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.; Kleppe R; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.; Erdal S; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.; Bustad HJ; Department of Biomedicine, University of Bergen, Bergen, Norway.; Bjørkhaug L; Department of Biomedical Laboratory Sciences and Chemical Engineering, Western Norway University of Applied Sciences, Bergen, Norway.; Haugarvoll K; Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Tzoulis C; Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Heimdal K; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; Knappskog PM; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Clinical Science, University of Bergen, Bergen, Norway.; Johansson S; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Clinical Science, University of Bergen, Bergen, Norway.; Aukrust I; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway ingvild.aukrust@helse-bergen.no.; Department of Clinical Science, University of Bergen, Bergen, Norway.

Publisher: Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 8102797 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1573-4935 (Electronic) Linking ISSN: 01448463 NLM ISO Abbreviation: Biosci Rep Subsets: MEDLINE

Gris-Oliver A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Palafox M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Monserrat L; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Brasó-Maristany F; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer, Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Òdena A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ibrahim YH; Weil Cornell Medicine, New York, New York.; Villacampa G; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Parés M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Bruna A; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge.; Hirst CS; Early Oncology, AstraZeneca, Cambridge, United Kingdom.; Barnicle A; Early Oncology, AstraZeneca, Cambridge, United Kingdom.; de Bruin EC; Early Oncology, AstraZeneca, Cambridge, United Kingdom.; Reddy A; Early Oncology, AstraZeneca, Cambridge, United Kingdom.; Schiavon G; Early Oncology, AstraZeneca, Cambridge, United Kingdom.; Arribas J; Growth Factors Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Mills GB; Department of Cell Development and Cancer Biology, Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Caldas C; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Dienstmann R; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer, Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic de Barcelona, Spain.; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Nuciforo P; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Razavi P; Department of Medicine and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Scaltriti M; Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Turner NC; Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London, United Kingdom.; Saura C; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Davies BR; Early Oncology, AstraZeneca, Cambridge, United Kingdom.; Oliveira M; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Larissa S. Carnevalli; Christopher J. Morrow; Teresa Klinowska; Simon T. Barry; Justin P.O. Lindemann; James S. Scott; Susan E. Critchlow; Violeta Serra; Mònica Sánchez-Guixé; Pei Zhang; Jonathan Cairns; Alan Rosen; Radoslaw Polanski; Daniel Sutton; Gareth Maglennon; Thomas A. Moss; Pablo Morentin-Gutierrez; Sladjana Gagrica; Ricardo J. Miragaia; Elisabetta Marangoni; Heloise Derrien; Elodie Montaudon; Jennifer Moss; Stuart C. Williamson; Neha Wali; Dawn Trueman; Hilary Lewis; Eric T. Gangl; David I. Fisher; Michelle DuPont; Oona Delpuech; Sophie D'Arcy; Jelena Urosevic; Azadeh Cheraghchi-Bashi; Susana Ros; Natalie Cureton; Mandy Lawson

Hierro, C.; Sanchez-Guixe, M.; Ruiz-Pace, F.; Jimenez, J.; Maynes, L.; Azaro, A.; Martin-Liberal, J.; Ochoa de Olza, M.; Brana, I.; Vieito, M.; Villanueva, A.; Palmer, H. G.; Arribas, J.; Nuciforo, P.; Vivancos, A.; Garralda, E.; Dienstmann, R.; Tabernero, J.; Serra, V.; Rodon, J.

ANNALS OF ONCOLOGY; SEP 2017, 28 1p. Supplement: 5